My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Qiagen N.V. Common Shares (NY:QGEN)

48.36 +0.23 (+0.48%)
Streaming Delayed Price Updated: 11:54 AM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 190,022
Open 48.06
Bid (Size) 48.35 (6)
Ask (Size) 48.38 (1)
Prev. Close 48.13
Today's Range 47.97 - 48.39
52wk Range 37.63 - 51.88
Shares Outstanding 227,985,334
Dividend Yield 0.52%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast
From QIAGEN N.V.
Via Business Wire
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property

Performance

YTD
+8.6%
+8.6%
1 Month
+6.1%
+6.1%
3 Month
+0.2%
+0.2%
6 Month
+18.8%
+18.8%
1 Year
+11.9%
+11.9%

More News

Read More
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio
From QIAGEN N.V.
Via Business Wire
Earnings Scheduled For August 5, 2025
Via Benzinga
A Look at Qiagen's Upcoming Earnings Report
Via Benzinga
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing
From QIAGEN N.V.
Via Business Wire
DoorDash To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
From QIAGEN N.V.
Via Business Wire
Earnings Scheduled For May 7, 2025
Via Benzinga
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels
From QIAGEN N.V.
Via Business Wire
QIAGEN N.V. (NYSE:QGEN) - A Strong Technical Setup for Breakout Investors
Via Chartmill
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast
From QIAGEN N.V.
Via Business Wire
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
From QIAGEN N.V..
Via Business Wire
QIAGEN N.V. (NYSE:QGEN) – A Quality Stock Worth Considering
Via Chartmill
QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership
From QIAGEN N.V.
Via Business Wire
Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism
Via Stocktwits
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
From QIAGEN N.V.
Via Business Wire
QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships
From QIAGEN N.V.
Via Business Wire
QIAGEN N.V. (NYSE:QGEN) – A Quality Stock with Strong Fundamentals
Via Chartmill
QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions
From QIAGEN N.V.
Via Business Wire
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software
From QIAGEN N.V.
Via Business Wire
QIAGEN announces plans for transition in leadership of Supervisory Board
From QIAGEN N.V.
Via Business Wire
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase
From QIAGEN N.V.
Via Business Wire
QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting
From QIAGEN N.V.
Via Business Wire
QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control
From QIAGEN N.V.
Via Business Wire

Frequently Asked Questions

Is Qiagen N.V. Common Shares publicly traded?
Yes, Qiagen N.V. Common Shares is publicly traded.
What exchange does Qiagen N.V. Common Shares trade on?
Qiagen N.V. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Qiagen N.V. Common Shares?
The ticker symbol for Qiagen N.V. Common Shares is QGEN on the New York Stock Exchange
What is the current price of Qiagen N.V. Common Shares?
The current price of Qiagen N.V. Common Shares is 48.36
When was Qiagen N.V. Common Shares last traded?
The last trade of Qiagen N.V. Common Shares was at 10/17/25 11:54 AM ET
What is the market capitalization of Qiagen N.V. Common Shares?
The market capitalization of Qiagen N.V. Common Shares is 11.03B
How many shares of Qiagen N.V. Common Shares are outstanding?
Qiagen N.V. Common Shares has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.